Search papers, labs, and topics across Lattice.
Division of Hematology, Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan
1
1
0
0
Emicizumab prophylaxis for hemophilia demonstrates comparable BMD outcomes to FVIII prophylaxis at one year, suggesting bleeding control is the primary driver of bone health, rather than the specific factor replacement strategy.
